Fisetin Lowers Inflammatory Markers in Cancer

S

Siim Land in his video 'The One Supplement to Rule Them All - NOVOS Core Review'

Quotes From Source

“Fisetin can reduce inflammatory markers such as CRP and MMPs ...”

Story of claim

Siim Land highlights fisetin's ability to reduce inflammatory markers CRP and MMPs in colorectal cancer patients, supporting anti-inflammatory treatment.

  • Goal: To reduce inflammation in colorectal cancer patients.
  • Proof: Fisetin's anti-inflammatory properties have been shown to reduce markers like CRP and MMPs.
  • Nuances:
    • Randomized control trial in 2018
    • Effect on colorectal cancer patients
    • No human clinical trials on senolytics yet
  • Impact on Life: Potential reduction in inflammation-related symptoms.

Investments

  • Price: $20-30 per month for NOVOS Core
  • Time: Effects observed in trials over weeks to months
  • Effort: Regular intake recommended

Risks

Low risk at standard doses, but specific effects need validation.

Get Started 🚀

  • Consider fisetin supplementation as part of anti-inflammatory treatment
  • Consult with a healthcare provider
  • Monitor inflammatory markers over time

Brogevity AI can make mistakes. Check important info.

Reference Video